Bromek, E.; Haduch, A.; Rysz, M.; Jastrzębska, J.; Pukło, R.; Wójcikowska, O.; Danek, P.J.; Daniel, W.A.
The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver. Pharmaceutics 2021, 13, 1643.
https://doi.org/10.3390/pharmaceutics13101643
AMA Style
Bromek E, Haduch A, Rysz M, Jastrzębska J, Pukło R, Wójcikowska O, Danek PJ, Daniel WA.
The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver. Pharmaceutics. 2021; 13(10):1643.
https://doi.org/10.3390/pharmaceutics13101643
Chicago/Turabian Style
Bromek, Ewa, Anna Haduch, Marta Rysz, Joanna Jastrzębska, Renata Pukło, Olga Wójcikowska, Przemysław Jan Danek, and Władysława Anna Daniel.
2021. "The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver" Pharmaceutics 13, no. 10: 1643.
https://doi.org/10.3390/pharmaceutics13101643
APA Style
Bromek, E., Haduch, A., Rysz, M., Jastrzębska, J., Pukło, R., Wójcikowska, O., Danek, P. J., & Daniel, W. A.
(2021). The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver. Pharmaceutics, 13(10), 1643.
https://doi.org/10.3390/pharmaceutics13101643